Barr Challenges Boehringer On Mirapex Patents
Barr Pharmaceuticals Inc.'s plans to market a generic version of Parkinson's disease drug Mirapex have prompted a lawsuit by drug originator Boehringer Ingelheim Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article